The Gross Margin of Glenmark Pharmaceuticals Ltd (GLENMARK.NS) is 63.30%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-03-31 | 63.30% |
| 2024-03-31 | 57.65% |
| 2023-03-31 | 59.44% |
| 2022-03-31 | 59.54% |
| 2021-03-31 | 60.46% |
| 2020-03-31 | 60.45% |
| 2019-03-31 | 60.17% |
| 2018-03-31 | 60.98% |
| 2017-03-31 | 67.11% |
| 2016-03-31 | 64.80% |